SCHEMBL2856420

SCHEMBL2856420

CCCCCCCCCCCCc1ccc(-c2nnc(-c3ccc(-c4nnc(-c5ccc(CCCCCCCCCCCC)cc5)c(-c5ccc(CCCCCCCCCCCC)cc5)n4)cc3)nc2-c2ccc(CCCCCCCCCCCC)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.55
▸ MAPT P10636 3/20 0.55
▸ KDM4E B2RXH2 3/20 0.55
▸ HSD17B10 Q99714 3/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ USP2 O75604 1/20 0.55
▸ GAA P10253 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ GPR84 Q9NQS5 1/20 0.53
▸ RARB P10826 5/20 0.50
▸ RARA P10276 1/20 0.50
▸ MTOR P42345 1/20 0.50
▸ HSD11B1 P28845 1/20 0.48
▸ TSHR P16473 1/20 0.47
▸ ESR1 P03372 2/20 0.47
▸ ADRA2A P08913 2/20 0.47
▸ ADORA3 P0DMS8 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11229908 0.86 ALDH1A1 (0.65) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL12622274 0.83 ALDH1A1 (0.65) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL12622306 0.81 ALDH1A1 (0.63) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL6736726 0.81 HSD17B10 (0.55) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL13539888 0.81 ALDH1A1 (0.62) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL11976539 0.77 ALDH1A1 (0.58) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL12628223 0.77 HSD11B1 (0.62) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL11927622 0.77 ALDH1A1 (0.58) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL13549537 0.77 ALDH1A1 (0.62) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL16615370 0.77 ALDH1A1 (0.58) ALDH1A1MAPTKDM4EHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816520-B2 Such as 1,4-Bis[5,6-(4,4'-dihydroxy)-diphenyl-1,2,4-triazin-3-yl]benzene; cosmetics for human skin, hair PIERRE FABRE DERMO-COSMETIQUE (FR) 2010-10-19 — — US claimed
EP-1753747-B1 5,6-DIPHENYL-1,2,4-TRIAZINIC DIMERIC DERIVATIVES AND THE USE THEREOF IN THE FORM OF SUN-PROTECTIVE AGENTS FABRE PIERRE DERMO COSMETIQUE (FR) 2010-01-13 — — EP claimed
US-20080267892-A1 Such as 1,4-Bis[5,6-(4,4'-dihydroxy)-diphenyl-1,2,4-triazin-3-yl]benzene; cosmetics for human skin, hair PIERRE FABRE DERMO-COSMETIQUE (FR) 2008-10-30 — — US claimed
EP-1753747-A1 5,6-DIPHENYL-1,2,4-TRIAZINIC DIMERIC DERIVATIVES AND THE USE THEREOF IN THE FORM OF SUN-PROTECTIVE AGENTS Pierre Fabre Dermo-Cosmetique (FR) 2007-02-21 — — EP claimed
WO-2005121128-A1 5,6-DIPHENYL-1,2,4-TRIAZINIC DIMERIC DERIVATIVES AND THE USE THEREOF IN THE FORM OF SUN-PROTECTIVE AGENTS PIERRE FABRE DERMO-COSMETIQUE (FR) 2005-12-22 — — WO claimed
US-7816520-B2 Such as 1,4-Bis[5,6-(4,4'-dihydroxy)-diphenyl-1,2,4-triazin-3-yl]benzene; cosmetics for human skin, hair PIERRE FABRE DERMO-COSMETIQUE (FR) 2010-10-19 — — US disclosed
EP-1753747-B1 5,6-DIPHENYL-1,2,4-TRIAZINIC DIMERIC DERIVATIVES AND THE USE THEREOF IN THE FORM OF SUN-PROTECTIVE AGENTS FABRE PIERRE DERMO COSMETIQUE (FR) 2010-01-13 — — EP disclosed
US-20080267892-A1 Such as 1,4-Bis[5,6-(4,4'-dihydroxy)-diphenyl-1,2,4-triazin-3-yl]benzene; cosmetics for human skin, hair PIERRE FABRE DERMO-COSMETIQUE (FR) 2008-10-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080267892-A1 Such as 1,4-Bis[5,6-(4,4'-dihydroxy)-diphenyl-1,2,4-triazin-3-yl]benzene; cosmetics for human skin, hair TYR, H1-0, TELO2 ALDH1A1 785/4885MAPT 4276/4885KDM4E 2393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback